Qiagen Plans Mid-Year Launch of Clinical NGS Platform; Says Gene Panels will Complement RT-PCR Tests | GenomeWeb

This article was originally published Jan. 8.

SAN FRANCISCO — Qiagen's CEO Peer Schatz said this week during a presentation at the JP Morgan Healthcare conference here that the company is on track to launch a clinically oriented next-gen sequencing system in the middle of this year.

Schatz added, however, that the platform is "simply a part of a complete solution" that involves leveraging Qiagen's broad array of tests, whether based on real-time PCR or sequencing, and "making that the complete solution for molecular diagnostics and biomedical research."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: transcriptional map of human embryo development, circadian clock genes in acute myeloid leukemia, and more.

The US National Academy of Sciences has announced 84 new members and 21 foreign associates.

The users of file-sharing site Sci-Hub work all around the globe where research is going on, Science's John Bohannon reports.

Researchers link obesity in Labrador retrievers to a deletion in their POMC gene.